Global Hepatitis Summit (GHS)’s Post

Today is Global #fattyliverday! Global Fatty Liver Day (formerly International NASH Day) is the premier, international education campaign that is convened by Global Liver Institute annually, on the 2nd Thursday of June, to raise visibility and urgency around the impact of fatty liver disease, and its more advanced form, on our communities. Fatty liver disease, often asymptomatic in its early stages, can progress to more sever condition such as liver cancer if left unchecked. At FUJIFILM Wako, we are dedicated to advancing liver cancer diagnostics. We offer opportunities for the early detection of liver fibrosis and Hepatocellular Carcinoma (HCC) using in vitro diagnostics. We are joining @globalliver to raise awareness about #fattyliverdisease in Germany, and strive to make a significant impact on liver health worldwide. #ActNowScreenToday #Fujifilm #Wako #Diagnostics #LiverDisease

🗓️ Join us on October 24th at 10:00 a.m. for the webinar: "Liver Cancer: It Is Never Too Early to Act". 💬 Experts will discuss the importance of prevention, early diagnosis, and patient-centric care in liver cancer. Don’t miss the chance to engage and learn how to reduce liver cancer's impact. Register now➡️ https://lnkd.in/eB5UvevJ #LiverCancerAwareness #LCAM #LCAM24 #Prevention #EarlyDiagnosis #DiCEEvent #NeverTooEarlyToAct Canadian Liver Foundation Global Liver Institute European Liver Patients' Association - ELPA European Foundation for the Study of Chronic Liver Failure (EF CLIF) International Liver Transplantation Society International Liver Cancer Association (ILCA) International Liver Cancer Movement EU Health and Food Safety EU Science, Research and Innovation WHO Regional Office for Europe IARC - International Agency for Research on Cancer / World Health Organization

🎗️On Liver Cancer Awareness Month, we unite with EASL | The Home of Hepatology, the European Liver Patients' Association - ELPA, the International Liver Cancer Association (ILCA) and the International Liver Cancer Movement to share key messages on the situation of #LiverCancer in Europe. The📽️video below is the first one, with an inspiring message from Zorana Maravic, Digestive Cancers Europe CEO, about how you can take proactive steps to reduce your risk of Liver Cancer by addressing modifiable risk factors. 👉 Learn more: https://lnkd.in/e6meuty9 #LiverCancerAwareness #LiverCancerAwarenessMonth #UnitedAgainstLiverCancer #LCAM #LCAM24 #Prevention Global Liver Institute EU Health and Food Safety EU Science, Research and Innovation International Liver Transplantation Society Blue Faery: The Adrienne Wilson Liver Cancer Association Liver Cancer Collaborative European Health and Digital Executive Agency (HaDEA) IARC - International Agency for Research on Cancer / World Health Organization World Health Organization European Cancer Organisation ECL Association of European Cancer Leagues Europacolon Portugal Fundacja EuropaColon Polska

At OWL Metabolomics, we believe it is crucial to bring the spotlight towards fatty liver disease, a condition affecting 115 million people worldwide. By 2030, this number is expected to skyrocket to 357 million. Often underdiagnosed due to subtle symptoms, fatty liver disease poses significant risks, including cirrhosis, liver cancer, and liver transplant. Our purpose is to raise awareness and promote preventive measures, such as our OWLiver panel the only non-invasive diagnostic test capable to detect at risk-MASH in any of its phases. Join us in this fight against fatty liver disease this #GlobalFattyLiverDay #MASH #HealthAwareness #LiverHealth #JoinTheMovement

🎉 We are thrilled to announce that our poster titled "A FECAL MICROBIAL SIGNATURE TO OPTIMISE COLORECTAL CANCER SURVEILLANCE IN LYNCH SYNDROME", presented during the Moderated Poster Session: Screening and Surveillance of CRC: What's New, has been awarded the Best Abstract Presentation Prize of the session at #UEGWeek! 🌟 This recognition highlights our innovative work, leveraging the gut microbiota to improve colorectal cancer surveillance, particularly in high-risk populations like those with Lynch Syndrome. 💪Winning this award motivates us to continue pushing the boundaries of digestive health and reinforces our commitment to transforming how colorectal cancer is detected and managed. UEG - United European Gastroenterology #GoodGut #colorectalcancer #gutmicrobiota #digestivehealth

Digestive Cancers are often preventable, detectable and treatable if the appropriate resources and strategies are implemented. 🔬 With Colorectal Cancer Awareness Month coming to an end, we call for increased investment in research, prevention and treatment of digestive cancers – today and every day. 📣 #EUNewsline #ECCAM2024 #CRC #myUEGcommunity ESDO - European Society of Digestive Oncology European Society of Gastrointestinal Endoscopy (ESGE) Digestive Cancers Europe

📣 Our HCC in Asia survey findings have been published in the Journal of Gastrointestinal Cancer 📣 'Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment' ➡️ A group of international and multidisciplinary clinical experts and Patient Advocacy Group representatives conducted the survey to investigate screening, diagnosis, therapeutic strategies, and patient journeys of hepatocellular carcinoma (HCC) across the Asia Pacific region. ➡️ Their aim was to offer a holistic understanding of HCC management and identify opportunities to improve outcomes for patients across Asia. ➡️The findings provided valuable insights and helped to identify key ways that the current approaches could be improved to enhance care and outcomes. Read the open-access article and download the accompanying slides 👉 https://ow.ly/5iN750SFTIV #MedicalEducation #Oncology This programme was supported by an Independent Medical Education Grant from Roche.

Primary Sclerosing Cholangitis (PSC) is an autoimmune disease affecting the bile ducts and liver. Most people with PSC also have Crohn's or Colitis. We know that some people with PSC go on to develop liver failure and so need a transplant, and some people with both PSC and Crohn's or Colitis have an increased risk of cancer of either the liver, bile ducts, gallbladder or bowel. Aspirin is a common drug used to treat pain and reduce the risk of heart attack and stroke. Recent clinical trials and research suggest that taking aspirin regularly may reduce the risk of developing some cancers in the general population. This UK-wide study will be the first to see if low dose aspirin is safe and effective in reducing the risk of cancer, as well as the need for liver transplantation, and in increasing overall survival, in people with both Crohn's or Colitis and Primary Sclerosing Cholangitis (PSC). Read below to learn how to take part in the clinical trial: https://ow.ly/MgEs50QS3fj #ResearchOpportunity #Crohns #Colitis #PSC #IBD

'Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment' We're proud to announce that the findings from our recent survey into HCC management in Asia have been published in the Journal of Gastrointestinal Cancer. 👉 A group of international and multidisciplinary clinical experts and Patient Advocacy Group representatives conducted the survey. 👉 They investigated the screening, diagnosis, therapeutic strategies, and patient journeys of hepatocellular carcinoma (HCC) across the Asia Pacific region. 👉 As liver cancer is the leading cause of cancer deaths in several Asian countries, these data can provide insight into the national approach to HCC management for each country, potential areas for improvement, and what to prioritise to shape national policies to improve outcomes for patients. Read the findings of the survey in the open-access article and download the accompanying slides 👉 https://ow.ly/2A8W50SFUAA #MedicalEducation #Oncology This programme was supported by an Independent Medical Education Grant from Roche.

Liver cancer cases have drastically increased in just one generation across🇪🇺. Now, over 50,000 people are diagnosed each year. Early detection saves lives! Watch the video below to learn why timely detection is crucial for catching #LiverCancer in its earliest stages when treatment is most effective. Wanna join the #LCAM campaign? Chcek👉 https://lnkd.in/e6meuty9 #LiverCancerAwareness #LiverCancerAwarenessMonth #UnitedAgainstLiverCancer #LCAM #LCAM24 #EarlyDiagnosis Global Liver Institute EU Health and Food Safety EU Science, Research and Innovation International Liver Transplantation Society Blue Faery: The Adrienne Wilson Liver Cancer Association Liver Cancer Collaborative European Health and Digital Executive Agency (HaDEA) IARC - International Agency for Research on Cancer / World Health Organization World Health Organization European Cancer Organisation ECL Association of European Cancer Leagues Europacolon Portugal Fundacja EuropaColon Polska EASL | The Home of Hepatology EASL the home of Hepatology International Cancer Patient Coalition International Liver Cancer Association (ILCA) International Liver Cancer Movement European Liver Patients' Association - ELPA